NCT04910503View on ClinicalTrials.gov

Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema

PHASE4RecruitingINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

April 30, 2030

Study Completion Date

April 30, 2030

Conditions

Diabetic Macular Edema

Interventions

DRUG

Dexamethasone intravitreal implant

Implant every 4 months if necessary

DRUG

Fluocinolone Acetonide Intravitreal Implant

Implantation

Trial Locations (1)

21 000

RECRUITING

CHU Dijon-Bourgogne, Dijon

All Listed Sponsors

lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT04910503 - Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema | Biotech Hunter | Biotech Hunter